- Home
- NBN vs BIOA Comparison
NBN vs BIOA Comparison
Compare NBN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBN | BIOA |
|---|---|---|
| Founded | 1872 | 2015 |
| Country | United States | United States |
| Employees | 234 | 62 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 933.4M | 776.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NBN | BIOA |
|---|---|---|
| Price | $124.55 | $18.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $117.50 | $51.50 |
| AVG Volume (30 Days) | 95.2K | ★ 416.7K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.77 | $720.93 |
| Revenue Next Year | $18.72 | N/A |
| P/E Ratio | $11.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $79.05 | $3.79 |
| 52 Week High | $127.00 | $24.00 |
Technical Indicators
Market Signals| Indicator | NBN | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 54.88 |
| Support Level | $104.40 | $18.53 |
| Resistance Level | $124.27 | $21.75 |
| Average True Range (ATR) | 3.55 | 1.14 |
| MACD | 0.70 | 0.24 |
| Stochastic Oscillator | 84.34 | 92.90 |
Price Performance
Historical ComparisonAbout NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.